
Opinion|Videos|December 19, 2024
New Systemic Treatment Options for Prurigo Nodularis
Author(s)TJ Chao, MPAS, PA-C
A collection of clinical insights on prurigo nodularis, exploring awareness and educational efforts as well as trends in treatment.
Advertisement
Episodes in this series

Video content above is prompted by the following:
There are two 2 systemic biologic treatments that have been recently approved for prurigo nodularis within the past few years. Can you describe these two 2 agents, including mechanisms of action, efficacy and safety, and what differentiates them from each other and from other PN treatment options?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Transformative Advances This Year and Beyond
5

















